|
||||||||||||||||||
|
||||||||||||||||||
|
||||||||||||||||||||||||||||||||||||||||||||||||||
Questions? Please consult our answers to frequently asked questions at http://www.ebioscience.com/faq. DescriptionThe 15F9 monoclonal antibody reacts with mouse ICOS (Inducible COStimulatory molecule), a T cell specific molecule and a third member of the CD28/CTLA-4 family. A homodimer of 47-57 kDa, ICOS is expressed on activated T cells, has potent costimulatory activity for T cell activation and proliferation and is required for humoral immune response. ICOS binds to its ligand on activated APC including B cells called B7h/B7RP-1 and is thought to play a protective role in inflammatory autoimmune diseases. ICOS may be involved in the development of Th2 cells. Applications ReportedFor research use only, not for diagnostic or therapeutic use. 15F9 has been reported for use in flow cytometric analysis. Applications TestedThe 15F9 antibody has been tested by flow cytometric analysis of mouse ConA-activated splenocytes. This can be used at less than or equal to 0.125 μg per million cells in a 100 μl total staining volume. It is recommended that the antibody be carefully titrated for optimal performance in the assay of interest. References
McAdam, A. J., T. T. Chang, et al. 2000. Mouse inducible costimulatory molecule (ICOS) expression is enhanced by CD28 costimulation and regulates differentiation of CD4+ T cells. J Immunol 165(9): 5035-40. Lucy S. K. Walker, Helen E. Wiggett, Fabrina M. C. Gaspal, Chandra R. Raykundalia, Margaret D. Goodall, Kai-Michael Toellner, and Peter J. L. Lane. 2003. Established T Cell-Driven Germinal Center B Cell Proliferation Is Independent of CD28 Signaling but Is Tightly Regulated Through CTLA-4. J Immunol. 170:91-98. Kohyama M, Sugahara D, Sugiyama S, Yagita H, Okumura K, Hozumi N. Inducible costimulator-dependent IL-10 production by regulatory T cells specific for self-antigen. Proc Natl Acad Sci U S A. 2004 Mar 23;101(12):4192-7. Epub 2004 Mar 10. (blocking, PubMed) Related ProductsCat. 15-4914 PE-Cy5 Golden Syrian Hamster IgG Isotype Control (clone n/a) Cat. 12-9942 PE anti-mouse ICOS (CD278) (clone 7E.17G9) Cat. 13-9942 Biotin anti-mouse ICOS (CD278) (clone 7E.17G9) Cat. 14-9942 Affinity Purified anti-mouse ICOS (CD278) (clone 7E.17G9) Cat. 15-9942 PE-Cy5 anti-mouse ICOS (CD278) (clone 7E.17G9) Cat. 16-9942 Functional Grade Purified anti-mouse ICOS (CD278) (clone 7E.17G9) Cat. 11-9949 FITC anti-mouse/rat ICOS (CD278) (clone C398.4A) Cat. 12-9949 PE anti-mouse/rat ICOS (CD278) (clone C398.4A) Cat. 13-9949 Biotin anti-mouse/rat ICOS (CD278) (clone C398.4A) Cat. 14-9949 Affinity Purified anti-mouse/rat ICOS (CD278) (clone C398.4A) Cat. 15-9949 PE-Cy5 anti-mouse/rat ICOS (CD278) (clone C398.4A) Cat. 16-9949 Functional Grade Purified anti-mouse/rat ICOS (CD278) (clone C398.4A) FOR NON-COMMERCIAL RESEARCH USE ONLY. NOT FOR THERAPEUTIC OR IN VIVO APLICATIONS. OTHER USE NEEDS LICENSE FROM AMERSHAM PHARMACIA BIOTECH INC. UNDER U.S. PATENT Nos. 4,981,977 AND 5,268,486 AND OTHER PATENTS PENDING. THIS MATERIAL IS SUBJECT TO PROPRIETARY RIGHTS OF AMERSHAM PHARMACIA BIOTECH INC. AND CARNEGIE MELLON UNIVERSITY AND MADE AND SOLD UNDER LICENSE FROM AMERSHAM PHARMACIA BIOTECH INC. THIS PRODUCT IS LICENSED FOR SALE ONLY FOR RESEARCH. IT IS NOT LICENSED FOR ANY OTHER USE. THERE IS NO IMPLIED LICENSE HEREUNDER FOR ANY COMMERCIAL USE. COMMERCIAL USE shall include: 1. Sale, lease, license or other transfer of the material or any material derived or produced from it. 2. Sale, lease, license or other grant of rights to use this material or any other material derived or produced from it 3. Use of this material to perform services for a fee for third parties. IF YOU REQUIRE A COMMERCIAL LICENSE TO USE THIS MATERIAL AND DO NOT HAVE ONE, RETURN THIS MATERIAL, UNOPENED TO eBioscience AND ANY MONEY PAID FOR THE MATERIAL WILL BE REFUNDED. |
||||||||||||||||||||||||||||||||||||||||||||||||||
![]() |
![]() |
|
Copyright © 2000-2008 eBioscience, Inc. Product For Research Use Only: Not for further distribution without written consent. |